Intravenous injection of plasma-derived exosomes can inhibit cyclin-dependent kinase 5 (CDK5)-mediated tau phosphorylation and reduce the formation of insoluble neurofibrillary tangles in AD mice by improving the bioavailability and brain delivery efficiency of quercetin [74]. Here, MAPT is linked to Alzheimer disease.